Study sheds light on determining surgical margins for feline tumors

June 13, 2017, Oregon State University

Researchers at Oregon State University are paving the way for more precision in determining surgical margins for an aggressive tumor common in cats by analyzing tissue contraction at various stages of the post-operative examination process.

The findings are important because inaccuracy in feline injection-site sarcoma surgical margins—the tissue cut out along with the tumor to try to ensure all cancerous cells are removed—can have a negative effect on the patient's health, whether the margin is bigger or smaller than necessary.

Understanding how margin length decreases from surgery to pathology - because of how the removed tissue shrinks and tumor cells invade surrounding tissues—can lead to better surgical margin planning and in turn a better prognosis, said corresponding author Milan Milovancev, a board-certified veterinary surgeon at OSU's College of Veterinary Medicine.

"If we can understand the relationship between what the pathologist sees on a slide under a microscope and what the surgeon is taking out in the operating room, and what accounts for the differences between the two, then we can work backward and figure out how much surgical margin to take," he said.

The pilot study looked at 35- to 55-millimeter surgical margins from five cats with feline injection site sarcoma, or FISS, and found the greatest margin decreases occurred right after excision. It also found the margins tended to be larger than necessary.

"Older studies showed that if you had bigger margins, cats would live longer," Milovancev said. "The previous margin guidelines of 2 to 3 centimeters had been found to be inadequate, and the new guidelines were 5, which seemed like a big jump and in some of these cats may cause a lot of unnecessary suffering.

"The net take-home is that yes, 2 to 3 centimeters is indeed inadequate, but we didn't find any tumors getting close to 5 centimeters. We can reduce morbidity by surgically removing what we need to take out and leaving what doesn't need to be taken out."

Milovancev notes that future, larger studies that categorize results by factors that might influence tumor-free margin length - such as tumor grade and location—are likely to lead to more refined preoperative surgical planning.

This pilot research builds on an earlier study by Milovancev and collaborators that examined the ability of MRIs and CT angiograms to detect related to FISS, and another study that looked at three methods for assessing margins for canine mast cell tumors and soft sarcomas.

In the imaging study, neither method definitely determined cancerous lesions from noncancerous ones and, surprisingly to the researchers, more than half the lesions thought to be cancerous on imaging turned out to be benign changes.

In the margin assessment research that involved more than 70 dogs, there was little agreement between the three techniques: imprint cytology, shaved margin histopathology and radial section histopathology.

"We'll follow up on the dogs and figure out which method best predicted regrowth," he said. "The methods weren't aligned in their results, so one of them is better than the other two."

Explore further: Trends in reoperation after initial lumpectomy for breast cancer

More information: Jesse L. Terry et al, Quantification of surgical margin length changes after excision of feline injection site sarcomas-A pilot study, Veterinary Surgery (2017). DOI: 10.1111/vsu.12602

Related Stories

Trends in reoperation after initial lumpectomy for breast cancer

June 5, 2017
Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus statement endorsing a minimal negative margin for invasive breast cancer on postlumpectomy ...

Combined optical and molecular imaging could guide breast-conserving surgery

June 1, 2017
Breast-conserving surgery (BCS) is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries. Now, in ...

Surgical probe seeks out where cancer ends and healthy tissue begins

September 17, 2015
A new surgical tool that uses light to make sure surgeons removing cancerous tumors "got it all" was found to correlate well with traditional pathologists' diagnoses in a clinical study, showing that the tool could soon enable ...

PERFI feasible for in vivo imaging of nonmelanoma skin cancer

June 4, 2017
(HealthDay)—Polarization-enhanced reflectance and fluorescence imaging (PERFI) is feasible for in vivo intraoperative imaging of nonmelanoma skin cancer (NMSC), according to a study published online May 25 in Lasers in ...

Computer-aided imaging technique could reduce risk of second breast cancer surgery

June 6, 2017
According to a recent study, one in four women with breast cancer who opt for a breast-saving lumpectomy will need a second surgery - increasing both costs and the risk of complications.

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.